MiMedx Group, Inc - Common Stock (MDXG)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- Trading 17% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 16.2% — good return on equity
- Revenue growing at 20% annually
MiMedx Group, Inc - Common Stock (MDXG) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $573 million . Key value metrics: P/E ratio 13.8, P/B ratio 2.24, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
MiMedx Group, Inc - Common Stock — Fundamental Analysis Summary
MiMedx Group, Inc - Common Stock (MDXG) is currently trading 17% above its Graham Number of $3.29, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 13.8x.
On financial health, MDXG shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 16.2% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.07.
StockPik's composite Value Score for MDXG is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDXG reports a high gross margin of 82.0% (sector average: 33.5%) and a solid operating margin of 14.0%.
MDXG shows revenue growing at 20% year-over-year, with earnings growing at 15%.